malignant melanotic nerve sheath tumor radiology mimicking a benign nerve sheath lesion: illustrative case in: Journal of Neurosurgery: Case Lessons Volume 10 Issue 20 (2025) Journals Malignant Melanotic Nerve Sheath Tumor

[DOI] [Google Scholar] 12.Bowman B.A.B

10.3945/an.110.1008 [DOI] [PMC free article] [PubMed] [Google Scholar] Wu G., Bazer F

Our customer service babes will be able to help

Clinical Studies The prolactin-lowering efficacy of DOSTINEX was demonstrated in 647 females with hyperprolactinemic disorders (including 55% microprolactinomas, 7% macroprolactinomas, 3% empty sella syndromes, and 3% idiopathic) in two randomized, double-blind, studies: one 4-week placebo-controlled dose-response study with an 12-month open-label extension (Study 1) and one 8-week active comparator study comparing DOSTINEX and bromocriptine with 16-week open extension (Study 2)

Thanks to Aaron for the suggestion